Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.56
-0.10 (-0.73%)
At close: Jul 17, 2026, 4:00 PM EDT
13.83
+0.27 (1.99%)
After-hours: Jul 17, 2026, 7:09 PM EDT
Generate Biomedicines Earnings Call Transcripts
Fiscal Year 2026
-
The platform integrates advanced computational and experimental methods to accelerate novel protein drug discovery, with a lead anti-TSLP antibody in phase III for severe asthma and a robust oncology pipeline. Strategic partnerships and a focus on biannual dosing aim to improve compliance and market impact.